Prudential Financial tower in Newark. - NJBIZ FILE PHOTO
Prudential Financial tower in Newark. - NJBIZ FILE PHOTO
Jessica Perry//July 17, 2025//
Prudential Financial Inc. has disclosed additional layoffs in New Jersey.
The company will cut 57 positions in Newark between the end of July and the middle of October of this year, according to a WARN notice filed with the state Department of Labor & Workforce Development.
The reductions are the latest announced by the Newark anchor institution. In November 2023, then Prudential CEO and Chairman Charles Lowrey disclosed impending workforce cuts in a memo to employees. Following three rounds of layoffs throughout 2024, the company announced more than 100 additional cuts in November.
That move brought total layoffs at Prudential to over 600 in 2024.
“Prudential Financial continually reviews its organizational structure to ensure it is meeting the evolving needs of its customers and maintaining its competitive position in the marketplace,” a Prudential spokesperson said in a statement to NJBIZ. “This includes periodically eliminating certain roles that no longer align with Prudential’s strategy.”
The financial institution celebrates its 150th year in business in 2025. In March, CEO Andrew Sullivan succeeded longtime leader Lowrey. Announced at the end of 2024, that transition was one of several among the company’s executive ranks that year.
The company plans to release its second quarter 2025 earnings July 30, after the market closes. A conference call with senior management will take place the following day. According to reports, preliminary Q2 results from Prudential indicate PGIM, its asset management business, had $1.44 trillion in AUM; other related revenues produced approximately $50 million.
The state has seen several large layoffs in 2025. In the financial space, JP Morgan Chase & Co. filed a WARN notice in May, bringing its total number of planned cuts in New Jersey to over 300 for 2025.
The pharmaceutical space has also seen a significant amount of turnover, from the likes of Bristol Myers Squibb, Kenvue and others.